ANGIOTECH PHARMACEUTICALS INC (ANPI) financial statements (2020 and earlier)

Company profile

Business Address 1618 STATION STREET
VANCOUVER, BC V6A 1B6
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments46
Cash and cash equivalents46
Short-term investments0
Receivables29
Inventory, net of allowances, customer advances and progress billings46
Inventory46
Deferred costs1
Prepaid expense and other current assets3
Income taxes receivable5
Other undisclosed current assets6
Total current assets:136
Noncurrent Assets
Property, plant and equipment31
Intangible assets, net (including goodwill)435
Goodwill124
Intangible assets, net (excluding goodwill)311
Deferred costs2
Prepaid expense and other noncurrent assets0
Assets held-for-sale, long lived2
Other undisclosed noncurrent assets1
Total noncurrent assets:472
TOTAL ASSETS:608
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:27
Employee-related liabilities13
Taxes payable5
Other undisclosed accounts payable and accrued liabilities9
Debt60
Deferred revenue and credits22
Other undisclosed current liabilities6
Total current liabilities:114
Noncurrent Liabilities
Long-term debt and lease obligation229
Long-term debt, excluding current maturities229
Liabilities, other than long-term debt124
Deferred revenue and credits25
Deferred tax liabilities, net89
Liability for uncertainty in income taxes10
Other liabilities1
Total noncurrent liabilities:353
Total liabilities:468
Stockholders' equity
Stockholders' equity attributable to parent141
Common stock204
Additional paid in capital7
Accumulated other comprehensive loss(4)
Accumulated deficit(67)
Total stockholders' equity:141
TOTAL LIABILITIES AND EQUITY:608

Income statement (P&L) ($ in millions)

12/31/2012
Revenues244
Revenue, net221
Cost of revenue(105)
Cost of goods and services sold(103)
Other undisclosed gross profit1
Gross profit:141
Operating expenses(112)
Other undisclosed operating loss(1)
Operating income:27
Nonoperating expense(25)
Income from continuing operations before income taxes:2
Income tax expense(8)
Net loss available to common stockholders, diluted:(6)

Comprehensive Income ($ in millions)

12/31/2012
Net loss:(6)
Comprehensive loss:(6)
Other undisclosed comprehensive income, net of tax, attributable to parent2
Comprehensive loss, net of tax, attributable to parent:(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: